Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination drug** consisting of: - **Nonsteroidal anti-inflammatory drugs (NSAIDs)**: a class of small molecule drugs that reduce pain and inflammation mainly by inhibiting cyclooxygenase (COX) enzymes, which are involved in prostaglandin synthesis. NSAIDs are commonly used to treat conditions such as **osteoarthritis** and other inflammatory diseases[2][3][1]. - **Sodium citrate**: a salt used as an alkalinizing agent, and in this context may serve to reduce gastrointestinal irritation caused by NSAIDs, although direct supporting evidence for this specific combination is limited. - **Glucosamine (often as sulfate or hydrochloride)**: an amino sugar used primarily as a dietary supplement for osteoarthritis; it is considered to have a chondroprotective effect, possibly by enhancing cartilage repair and reducing joint pain. Recent evidence indicates that glucosamine, especially **glucosamine hydrochloride (GS-HCl)**, may also exert a *synergistic* or *NSAID-sparing effect* by inhibiting the glycosylation of COX-2, and therefore may reduce NSAID-induced gastric damage while maintaining anti-arthritic efficacy[1][2][3][5]. No unique brand or code names are associated with this specific triple combination, but several studies investigate NSAIDs + glucosamine in osteoarthritis (mainly with celecoxib, meloxicam, etoricoxib, ibuprofen, or piroxicam), and combinations are often provided as multi-ingredient supplements or compounded drugs[2][3][1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nsaids + sodium citrate + glucosamine.